Nucleoside analogue therapy in fibrosing cholestatic hepatitis - A case report in an HBsAg positive renal transplant recipient

Liver

Volumn 18, Issue 2, 1998, Pages 134-139

  Brind, A M ^a   Bennett, M K ^a   Bassendine, M F ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Fibrosing cholestatic hepatitis; Hepatitis B virus pre core mutant; Lamivudine; Nucleoside analogues; Transplantation

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B(E) ANTIBODY; LAMIVUDINE; NUCLEOSIDE ANALOG; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CAUSE OF DEATH; CHOLESTATIC HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATORENAL SYNDROME; HUMAN; INFECTION PREVENTION; JAUNDICE; KIDNEY TRANSPLANTATION; LACTIC ACIDOSIS; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; POSTOPERATIVE COMPLICATION;

EID: 0031955087     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00139.x     Document Type: Article

References (31)

1. DAVIES S E, PORTMAN B C, O'GRADY J G, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150-7.
2. LUCEY M R, GRAHAM D M, MARTIN P, et al. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 1992; 33: 1390-6.
3. HARRISON R F, DAVIES M H, GOLDIN R D, HUBSCHER S G. Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis. Histopathology 1993; 23: 21-8.
4. MASON A L, WICK M, WHITE H M, et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993; 105: 237-44.
5. FANG J W S, TUNG F Y T, DAVIS G L, DOLSON D J, VAN THIEL D H, LAU J Y N. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. Gastroenterology 1993; 105: 901-4.
6. WALKER N, APEL R, KERLIN P, et al. Hepatitis B virus infection in liver allografts. Am J Surg Pathol 1993; 17: 666-77.
7. ANGUS P W, LOCARNINI S A, MCCAUGHAN G W, JONES R M, MCMILLAN J S, BOWDEN D S. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 1995; 21: 14-8.
8. HAWKINS A E, GILSON R J, GILBERT N, et al. Hepatitis B surface mutations associated with infection after liver transplantation. J Hepatol 1996; 24: 8-14.
9. JAMAL H, REGENSTEIN F, FARR G, PERRILLO R P. Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy. Am J Gastroenterol 1996; 91: 1027-30.
10. BOOTH J C L, GOLDIN R D, BROWN J L, KARAYIANNIS P, THOMAS H C. Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant. J Hepatol 1995; 22: 500-3.
11. CHEN C-H, CHEN P-J, CHU J-S, YEH K-H, LAI M-Y, CHEN D-S Fibrosing cholestaic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. Gastroenterology 1994; 107: 1514-18.
12. HUNG Y B, LIANG J T, CHU J S, CHEN K M, LEE C S. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis. Hepatogastroenterology 1995; 42: 913-8.
13. LAM P W, WACHS M E, SOMBERG K A, VINCENTI F, LAKE J R, FERRELL L D. Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation 1996; 61: 378-81.
14. MCIVOR C, MORTON J, BRYANT A, COOKSLEY G, DURRANT S, WALKER N. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann Intern Med 1994; 121: 274-5.
15. FANG J W S, WRIGHT T L, LAU J Y N. Fibrosing cholestatic hepatitis in a patient with HIV and hepatitis B. Lancet 1993; 342: 1175.
16. LAU J Y N, BAIN V G, DAVIES S E, et al. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102: 956-62.
17. YOSHIBA M, SEKIYAMA K, SUGATA F, OKAMOTO H, YAMAMOTO K, YOTSUMOTO S. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 1992; 37: 1253-9.
18. DIENSTAG J L, PERRILLO R P, SCHIFF E R, BARTHOLOMEW M, VICARY C, RUBIN M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657-61.
19. MULLER R, SAMUEL D, FASSATI L R, BENHAMOU L P, BISMUTH H, ALEXANDER G J. "Eurohep" consensus report on the management of liver transplantation for hepatitis B infection. J Hepatol 1994; 21: 1140-3.
20. TUR-KASPA R, BURK R D, SHAUL Y, SHAFRITZ D A. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 1986; 83: 1627-31.
21. LAU J, BAIN V, SMITH H, ALEXANDER G, WILLIAMS R. Modulation of hepatitis B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. Transplantation 1992; 53: 894-8.
22. ROINGEARD P, ROMET-LEMONNE J-L, LETURCQ D, GOUDEAU A, ESSEX M. Hepatitis B virus core antigen (HBcAg) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect. Virology 1990; 179: 113-20.
23. CHISARI F, FILIPPI P, BURAS J, et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 1987; 84: 6909-13.
24. MCKENZIE R, FRIED M W, SALLIE R, et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Eng J Med 1995; 333: 1099-105.
25. GRELLIER L, MUTIMER D, AHMED M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212-5.
26. SCHALM S W, DEMAN R A, HEYTINK R A, NEITERS HGM. New nucleoside analogues for chronic hepatitis B. J Hepatol 1995, 22: 52-6
27. HONKOOP P, DE MAN R A, HEIJTINK R A, SCHALM S W. Hepatitis B reactivation after lamivudine. Lancet 1995; 346: 1156-7.
28. LING R, MUTIMER D, BOXALL E H, ELIAS E, DUSHIEKO G M, HARRISON T J. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24: 711-3.
29. TIPPLES G A, MA M M, FISCHER K P, BAIN V G, KNETEMAN N M, TYRELL D L J. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24: 714-7.
30. BARTHOLOMEW M M, JANSEN R W, JEFFERS L J, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349: 20-2.
31. FONTANA R J, LOK A S F. Combination therapy for chronic hepatitis B. Hepatology 1997; 26: 234-7.